Selective determinants of inositol 1,4,5‐trisphosphate and adenophostin A interactions with type 1 inositol 1,4,5‐trisphosphate receptors
Open Access
- 2 July 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 161 (5) , 1070-1085
Abstract
BACKGROUND AND PURPOSEAdenophostin A (AdA) is a potent agonist of inositol 1,4,5‐trisphosphate receptors (IP3R). AdA shares with IP3the essential features of all IP3R agonists, namely structures equivalent to the 4,5‐bisphosphate and 6‐hydroxyl of IP3, but the basis of its increased affinity is unclear. Hitherto, the 2′‐phosphate of AdA has been thought to provide a supra‐optimal mimic of the 1‐phosphate of IP3.EXPERIMENTAL APPROACHWe examined the structural determinants of AdA binding to type 1 IP3R (IP3R1). Chemical synthesis and mutational analysis of IP3R1 were combined with3H‐IP3binding to full‐length IP3R1 and its N‐terminal fragments, and Ca2+release assays from recombinant IP3R1 expressed in DT40 cells.KEY RESULTSAdenophostin A is at least 12‐fold more potent than IP3in functional assays, and the IP3‐binding core (IBC, residues 224–604 of IP3R1) is sufficient for this high‐affinity binding of AdA. Removal of the 2′‐phosphate from AdA (to give 2′‐dephospho‐AdA) had significantly lesser effects on its affinity for the IBC than did removal of the 1‐phosphate from IP3(to give inositol 4,5‐bisphosphate). Mutation of the only residue (R568) that interacts directly with the 1‐phosphate of IP3decreased similarly (by ∼30‐fold) the affinity for IP3and AdA, but mutating R504, which has been proposed to form a cation‐π interaction with the adenine of AdA, more profoundly reduced the affinity of IP3R for AdA (353‐fold) than for IP3(13‐fold).CONCLUSIONS AND IMPLICATIONSThe 2′‐phosphate of AdA is not a major determinant of its high affinity. R504 in the receptor, most likely via a cation‐π interaction, contributes specifically to AdA binding.Keywords
This publication has 49 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- Synthetic partial agonists reveal key steps in IP3 receptor activationNature Chemical Biology, 2009
- Activation of IP3 receptors by synthetic bisphosphate ligandsChemical Communications, 2009
- Molecular Basis of the Isoform-specific Ligand-binding Affinity of Inositol 1,4,5-Trisphosphate ReceptorsJournal of Biological Chemistry, 2007
- Inositol Trisphosphate Receptor Ca2+Release ChannelsPhysiological Reviews, 2007
- Calcium signalling: dynamics, homeostasis and remodellingNature Reviews Molecular Cell Biology, 2003
- Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligandNature, 2002
- Inframolecular Studies of the Protonation of Adenophostin A: Comparison with 1-d-myo-Inositol 1,4,5-TrisphosphateBiochemical and Biophysical Research Communications, 1999
- Adenophostin‐medicated quantal Ca2+ release in the purified and reconstituted inositol 1,4,5‐trisphosphate receptor type 1FEBS Letters, 1995
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973